HR572-119

In Committee

RED TAPE Act

119th Congress Introduced Jan 21, 2025

Summary

What This Bill Does

The RED TAPE Act changes how agencies justify regulations under the Regulatory Flexibility Act and related OMB review frameworks. It defines benefit-cost analysis and regulatory impact analysis by reference to OMB Circular A-94, executive orders on regulatory review, and OMB Circular A-4. Agencies may not consider non-monetized or unquantified factors in regulatory impact or benefit-cost analyses for proposed, final, or interim final rules. OMB may not authorize, endorse, or itself consider those factors in guidance, memoranda, directives, rules, or review of another agency's analysis. Agencies must publish in the Federal Register, with each covered rule, summaries and full text of each analysis, methodology, economic impact estimates, rationale, and other decision-making information. OMB must issue revised guidance within 90 days. Affected parties may sue in federal district court if an agency considered a banned factor, and courts must declare a final or interim final rule invalid if the agency relied on non-monetized or unquantified factors. The judicial-review rule applies to rules issued on or after November 9, 2023.

Who Benefits and How

Regulated businesses benefit because agencies must justify rules using monetized or quantified analysis and publish the methodology. Parties challenging regulations benefit from an explicit federal cause of action and invalidation remedy. OMB regulatory review staff benefit from a clear statutory directive to revise guidance and police agency analyses. Cost-benefit analysts benefit from stronger demand for quantified economic impact analysis in rulemaking.

Who Bears the Burden and How

Federal agency economists must remove non-monetized or unquantified factors and publish detailed methods and rationale. OMB regulatory review staff must revise guidance within 90 days and stop approving banned analytical factors. Public health and environmental advocates may bear reduced weight for benefits that are difficult to monetize or quantify. Federal courts must hear challenges and invalidate rules that rely on prohibited factors.

Key Provisions

  • Defines benefit-cost analysis and regulatory impact analysis through OMB circulars and regulatory review orders.
  • Prohibits agencies from considering non-monetized or unquantified factors in covered rule analyses.
  • Prohibits OMB from authorizing, endorsing, or considering those factors.
  • Requires Federal Register publication of summaries, full analyses, methods, estimates, rationale, and decision-making information.
  • Requires OMB revised guidance within 90 days.
  • Creates district-court challenges and rule invalidation for violations, applying to rules issued on or after November 9, 2023.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Bars federal agencies and OMB from using non-monetized or unquantified factors in regulatory impact or benefit-cost analyses, requires Federal Register publication of analysis summaries, methods, and rationale, directs OMB guidance within 90 days, and lets affected parties sue to invalidate rules that rely on banned factors.

Key Policy Areas

Regulation, Administrative Law, Cost-Benefit Analysis

Primary Purpose

Bars federal agencies and OMB from using non-monetized or unquantified factors in regulatory impact or benefit-cost analyses, requires Federal Register publication of analysis summaries, methods, and rationale, directs OMB guidance within 90 days, and lets affected parties sue to invalidate rules that rely on banned factors.

Policy Domains

Regulation Administrative Law Cost-Benefit Analysis

Resolution provisions

Identified Gains
  • Regulated businesses
  • Parties challenging regulations
  • OMB regulatory review staff
  • Cost-benefit analysts
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Regulated businesses: ,
Cost-benefit analysts: ,
OMB regulatory review staff: ,
Parties challenging regulations: ,
Identified Costs
  • Federal agency economists
  • OMB regulatory review staff
  • Public health advocates
  • Federal courts
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Federal courts: ,
Public health advocates: ,
Federal agency economists: ,
OMB regulatory review staff: ,

Legislative Progress

In Committee
Introduced Committee Passed
Jan 21, 2025

Mr. Sessions (for himself and Ms. Hageman) introduced the following …

Jan 21, 2025

Referred to the Committee on the Judiciary, and in addition …

Jan 21, 2025

Introduced in House

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Government
4 mentions across 2 clauses
-4 negative

Federal agency economists, OMB regulatory review staff

Small Business
2 mentions across 2 clauses
+2 positive

Regulated businesses

Professional Services
2 mentions across 2 clauses
+2 positive

Parties challenging regulations

General Public
2 mentions across 2 clauses
-2 negative

Public health advocates

Judiciary
2 mentions across 2 clauses
-2 negative

Federal courts

2/5
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Regulation Administrative Law Cost-Benefit Analysis

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology